Singapore-based Biotech startup Automera has received $16 million in Series A funding co-led by US-based Accelerator Life Science Partners (ALSP) and Temasek-backed ClavystBio.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $52.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
